Dashboard
Manage Tickers

QURE uniQure N.V.

Nasdaq uniqure.com


$ 31.20 $ 11.00 (47.41 %)    

Monday, 03-Nov-2025 19:52:04 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 629.78 $ -3.11 (-0.49 %)
DIA $ 472.70 $ -2.66 (-0.56 %)
SPY $ 681.88 $ -2.29 (-0.33 %)
TLT $ 89.68 $ 0.07 (0.08 %)
GLD $ 366.72 $ 0.05 (0.01 %)
$ 34.29
$ 23.20
$ 31.00 x 610
$ 33.05 x 10
$ 22.85 - $ 36.19
$ 5.35 - $ 71.50
30,500,286
na
1.88B
$ 1.28
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-29-2025 06-30-2025 10-Q
2 05-09-2025 03-31-2025 10-Q
3 02-27-2025 01-01-1970 10-K
4 11-05-2024 09-30-2024 10-Q
5 08-01-2024 06-30-2024 10-Q
6 05-07-2024 03-31-2024 10-Q
7 02-28-2024 12-31-2023 10-K
8 11-07-2023 09-30-2023 10-Q
9 08-01-2023 06-30-2023 10-Q
10 05-09-2023 03-31-2023 10-Q
11 02-27-2023 12-31-2022 10-K
12 11-02-2022 09-30-2022 10-Q
13 08-08-2022 06-30-2022 10-Q
14 05-02-2022 03-31-2022 10-Q
15 02-25-2022 12-31-2021 10-K
16 10-25-2021 09-30-2021 10-Q
17 07-26-2021 06-30-2021 10-Q
18 05-10-2021 03-31-2021 10-Q
19 03-01-2021 12-31-2020 10-K
20 10-27-2020 09-30-2020 10-Q
21 07-30-2020 06-30-2020 10-Q
22 04-29-2020 03-31-2020 10-Q
23 03-02-2020 12-31-2019 10-K
24 10-28-2019 09-30-2019 10-Q
25 07-29-2019 06-30-2019 10-Q
26 04-29-2019 03-31-2019 10-Q
27 02-28-2019 12-31-2018 10-K
28 11-06-2018 09-30-2018 10-Q
29 08-08-2018 06-30-2018 10-Q
30 04-30-2018 03-31-2018 10-Q
31 03-14-2018 12-31-2017 10-K
32 11-01-2017 09-30-2017 10-Q
33 08-08-2017 06-30-2017 10-Q
34 05-09-2017 03-31-2017 10-Q
35 03-15-2017 12-31-2016 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

chardan-capital-maintains-buy-on-uniqure-lowers-price-target-to-53
Chardan Capital Maintains Buy on uniQure, ...
11/03/2025 21:32:33

Chardan Capital analyst Daniil Gataulin maintains uniQure (NASDAQ:QURE) with a Buy and lowers the price target from $76 to $53.

gold-edges-higher-ism-manufacturing-pmi-falls-in-october
Gold Edges Higher; ISM Manufacturing PMI F...
11/03/2025 19:23:45

uniqure-shares-drop-after-fda-shifts-stance-on-huntingtons-gene-therapy-data
UniQure Shares Drop After FDA Shifts Stanc...
11/03/2025 18:04:59

UniQure shares fell after the FDA questioned the adequacy of data supporting its AMT-130 gene therapy for Huntington's dise...

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
11/03/2025 17:05:47

nasdaq-surges-1-on-semiconductor-posts-upbeat-q3-earnings
Nasdaq Surges 1%; ON Semiconductor Posts U...
11/03/2025 14:44:30

kimberly-clark-vertex-and-other-big-stocks-moving-lower-in-mondays-pre-market-session
Kimberly-Clark, Vertex And Other Big Stock...
11/03/2025 13:14:55

uniqure-receives-feedback-from-fda-during-pre-bla-meeting-regarding-amt-130-investigational-gene-therapy-for-hd
uniQure Receives Feedback From FDA During ...
11/03/2025 12:17:23

uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical ...

Core News & Articles
10 Health Care Stocks Whale Activity In To...
10/30/2025 17:35:24

why-is-protalix-biotherapeutics-stock-falling-on-friday
Why Is Protalix BioTherapeutics Stock Fall...
10/17/2025 15:23:15

EMA issues a negative opinion on Protalix and Chiesi's Elfabrio revised dosing for Fabry disease, citing insufficient data ...

cramer-warns-on-one-chip-stock-says-broadcom-is-the-better-bet
Cramer Warns On One Chip Stock, Says Broad...
10/06/2025 12:48:55

Jim Cramer recommends caution with Ambiq Micro (AMBQ) and suggests Broadcom (AVGO). He dislikes Albertsons (ACI) and advises se...

hc-wainwright--co-maintains-buy-on-uniqure-raises-price-target-to-110
HC Wainwright & Co. Maintains Buy on uniQu...
10/06/2025 10:41:46

HC Wainwright & Co. analyst Patrick R. Trucchio maintains uniQure (NASDAQ:QURE) with a Buy and raises the price target f...

wells-fargo-maintains-overweight-on-uniqure-raises-price-target-to-80
Wells Fargo Maintains Overweight on uniQur...
10/02/2025 14:32:07

Wells Fargo analyst Yanan Zhu maintains uniQure (NASDAQ:QURE) with a Overweight and raises the price target from $65 to $80.

Core News & Articles
10 Health Care Stocks Whale Activity In To...
10/01/2025 17:35:33

benzinga-bulls-and-bears-oracle-costco-nio--and-wall-street-snaps-its-slide
Benzinga Bulls And Bears: Oracle, Costco, ...
09/27/2025 12:04:13

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our t...

reported-earlier-uniqure-announces-pricing-of-upsized-300m-public-offering-of-5789473-ordinary-shares-at-4750-per-share
Reported Earlier, uniQure Announces Pricin...
09/26/2025 07:06:00

goldman-sachs-maintains-neutral-on-uniqure-raises-price-target-to-56
Goldman Sachs Maintains Neutral on uniQure...
09/25/2025 17:22:09

Goldman Sachs analyst Salveen Richter maintains uniQure (NASDAQ: QURE) with a Neutral and raises the price target from $13 t...

mizuho-maintains-outperform-on-uniqure-raises-price-target-to-60
Mizuho Maintains Outperform on uniQure, Ra...
09/25/2025 16:25:04

Mizuho analyst Uy Ear maintains uniQure (NASDAQ: QURE) with a Outperform and raises the price target from $30 to $60.

guggenheim-maintains-buy-on-uniqure-raises-price-target-to-95
Guggenheim Maintains Buy on uniQure, Raise...
09/25/2025 12:57:42

Guggenheim analyst Debjit Chattopadhyay maintains uniQure (NASDAQ: QURE) with a Buy and raises the price target from $28 to ...

cantor-fitzgerald-maintains-overweight-on-uniqure-raises-price-target-to-80
Cantor Fitzgerald Maintains Overweight on ...
09/25/2025 12:52:28

Cantor Fitzgerald analyst Kristen Kluska maintains uniQure (NASDAQ: QURE) with a Overweight and raises the price target from...

uniqure-stocks-248-blastoff-was-just-the-start--ask-wall-street
UniQure Stock's 248% Blastoff Was Just The...
09/25/2025 12:37:02

UniQure NV (NASDAQ: QURE) just staged one of biotech's wildest rides of the year, soaring 248% in a single session after un...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION